Condition

PMF (2)

Primary Myelofibrosis (2)

Myelofibrosis (1)

Post-ET MF (1)

Post-Essential Thrombocythemia Myelofibrosis (1)

Post-PV MF (1)

Post-Polycythemia Vera Myelofibrosis (1)

SMF (1)

Secondary Myelofibrosis (1)

Overall Status

Active, not recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Novartis Pharmaceuticals (1)

University of Ulm (1)

Collaborator

Intervention

decitabine (1)

incb018424/cc-4047 (1)

mbg453 (1)

nis793 (1)

spartalizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

pmf

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Primary Myelofibrosis, Secondary Myelofibrosis, PMF Trial in Germany (INCB018424/CC-4047)

Active, not recruiting

Primary Myelofibrosis
+5 more

INCB018424/CC-4047

Aachen, Germany
+16 more

Sep 28, 2021

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn

Primary Myelofibrosis
+4 more

MBG453
+3 more

(no location specified)

Mar 2, 2021